NASDAQ:SABS | Income Statement | SAB Biotherapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$16.17M$23.38M-$23.38M$886,000.00-$22.49M-$0.28-$0.2879,753,10079,753,100
2026-03-31$13.4M$20M-$20M$1.13M-$18.87M-$0.35-$0.3553,558,63953,558,639
2025-12-31$10.73M$15.77M-$15.77M-$1.09M-$16.86M-$0.51-$0.469,561,26731,037,303
2025-09-30$8.97M$12.68M-$12.68M$58.12M$45.45M$0.50-$0.2110,660,50077,863,263
2025-06-30$7M$9.73M-$9.73M-$382,000.00-$10.11M-$1.09-$1.099,294,4699,294,469
2025-03-31$7.66M$10.77M-$10.77M$5.58M-$5.2M-$0.56-$0.569,291,6419,291,641
2024-12-31$114,698.00$7.65M$10.12M-$10.01M-$1.39M-$11.39M-$1.23-$1.239,8239,823
2024-09-30$7.83M$11.31M-$11.31M$959,956.00-$10.35M-$10.35M-$1.12-$1.129,259,1929,259,192
2024-06-30$263,137.00$6.82M$10.46M-$10.2M$2.87M-$7.34M-$7.34M-$0.79-$0.799,255,0259,255,025
2024-03-31$944,575.00$8.15M$12.34M-$11.39M$6.36M-$5.03M-$5.03M-$0.54-$0.549,241,9409,241,940
2023-12-31$305,011.00$4.3M$19.18M-$18.87M-$3.98M-$22.86M-$22.86M-$3.85-$3.85413,023413,023
2023-09-30$1.27M$4.02M$6.59M-$5.32M$220,605.00-$5.1M-$5.1M-$0.97-$0.975,240,6005,240,600
2023-06-30$85,518.00$3.66M$6.56M-$6.48M-$404,268.00-$6.88M$0.00-$6.88M-$1.36-$1.365,042,1265,042,126
2023-03-31$581,101.00$4.54M$7.98M-$7.4M$48,189.00-$7.35M$0.00-$7.35M-$1.46-$1.465,039,7055,039,705
2022-12-31$2.16M$7.14M$10.02M-$7.86M$11,043.00-$7.85M-$7.87M-$4.06-$4.06-38,689,882-38,689,882
2022-09-30$3.59M$7.35M$11.4M-$7.81M$731,248.00-$7.08M-$7.08M-$0.16-$0.1643,030,88543,030,885
2022-06-30$6.35M$8.58M$12.89M-$6.54M$1.67M-$4.87M-$92,281.00-$4.78M-$0.11-$0.1142,999,41342,999,413
2022-03-31$11.8M$13.32M$18.51M-$6.71M$7.79M$1.08M$92,281.00$985,863.00$0.02$0.0243,113,35345,816,651
2021-12-31$11.06M$10.65M$18.4M-$7.34M-$4.21M-$11.55M-$11.55M-$0.41-$0.411,365,7741,365,774
2021-09-30$14.68M$15.07M$18.67M-$3.99M-$70,836.00-$4.06M-$4.06M-$0.16-$0.1625,973,40625,973,406
2021-06-30$18.21M$18.68M$21.08M-$2.87M-$1.95M-$2.94M-$2.94M-$0.11-$0.1125,973,40625,973,406
2021-03-31$16.93M$12.78M$16.11M$813,924.00$3.08M$1.41M$1.41M$0.05$0.0525,973,40628,072,567

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$34.35M$48.95M-$48.95M$62.23M$13.27M$0.00$13.27M$0.22-$0.7919,311,79861,340,193
2024-12-31$1.32M$30.25M$44.23M-$42.91M$8.81M$0.00-$34.11M-$3.68-$3.689,261,9189,261,918
2023-12-31$2.24M$16.52M$40.31M-$38.08M-$4.12M-$42.19M$0.00-$42.19M-$7.64-$7.645,521,4875,521,487
2022-12-31$23.9M$36.44M$52.82M-$28.92M$10.2M-$18.72M$25,629.00-$18.74M-$4.31-$4.314,352,4974,352,497
2021-12-31$60.88M$57.18M$74.27M-$13.39M-$3.75M-$17.14M$0.00-$17.14M-$0.63-$0.6327,339,18027,339,180
2020-12-31$55.24M$27.91M$34.68M$20.56M$20.12M$0.00$20.12M$0.79$0.7425,391,08427,011,482

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.